» Articles » PMID: 34121749

Evaluation of the Sperm DNA Fragmentation Index in Infertile Japanese Men by In-house Flow Cytometric Analysis

Overview
Journal Asian J Androl
Specialty Urology
Date 2021 Jun 14
PMID 34121749
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Semen analysis has long been used to evaluate male fertility. Recently, several sperm function tests have been developed. Of those, the sperm DNA fragmentation index (DFI), which describes the status of the sperm DNA, is thought to be a suitable parameter for evaluating male fertility. However, there have been no large-scale studies on the sperm DFI of Japanese men. Therefore, we investigated the feasibility of using an in-house flow cytometry-based sperm DFI analysis based on the sperm DNA fragmentation test of sperm chromatin structure assay (SCSA) to assess male fertility in Japan. This study enrolled 743 infertile and 20 fertile Japanese men. To evaluate reproducibility, inter- and intraobserver precision was analyzed. A receiver operating characteristic curve analysis was used to set a cutoff value for the sperm DFI to identify men who could father children by timed intercourse or intrauterine insemination. The variability of the sperm DFI among fertile volunteers was determined. The relationship between semen parameters and the sperm DFI was assessed by Spearman's rho test. A precision analysis revealed good reproducibility of the sperm DFI. The cutoff value of sperm DNA fragmentation in infertile men was 24.0%. Semen volume had no relationship with the sperm DFI. Sperm concentration, sperm motility, total motile sperm count, and percentage of normal-shaped sperm were significantly and negatively correlated with the sperm DFI. The median sperm DFI was smaller in fertile volunteers (7.7%) than that in infertile men (19.4%). Sperm DNA fragmentation analysis can be used to assess sperm functions that cannot be evaluated by ordinary semen analysis.

Citing Articles

Sperm DNA fragmentation index: limited effectiveness on predicting embryo quality in assisted reproduction technology treatments.

Jiang H, Xia X, Luo Y, Pan H, Qu S, Xu J Reprod Biol Endocrinol. 2025; 23(1):14.

PMID: 39863907 PMC: 11763148. DOI: 10.1186/s12958-025-01345-8.


Impact of antioxidants in improving semen parameters like count, motility and DNA fragmentation in sub-fertile males: a randomized, double-blind, placebo-controlled clinical trial.

Patki A, Shelatkar R, Singh M, Agarwal S, M V, Umbardand S Transl Clin Pharmacol. 2023; 31(1):28-39.

PMID: 37034126 PMC: 10079508. DOI: 10.12793/tcp.2023.31.e6.

References
1.
Evenson D . Sperm chromatin structure assay (SCSA®). Methods Mol Biol. 2012; 927:147-64. DOI: 10.1007/978-1-62703-038-0_14. View

2.
Shi X, Chan C, Waters T, Chi L, Chan D, Li T . Lifestyle and demographic factors associated with human semen quality and sperm function. Syst Biol Reprod Med. 2018; 64(5):358-367. DOI: 10.1080/19396368.2018.1491074. View

3.
Zhu X, Chen Q, Fan W, Niu Z, Xu B, Zhang A . Sperm DNA fragmentation in Chinese couples with unexplained recurrent pregnancy loss. Asian J Androl. 2019; 22(3):296-301. PMC: 7275799. DOI: 10.4103/aja.aja_60_19. View

4.
Chohan K, Griffin J, Lafromboise M, De Jonge C, Carrell D . Comparison of chromatin assays for DNA fragmentation evaluation in human sperm. J Androl. 2006; 27(1):53-9. DOI: 10.2164/jandrol.05068. View

5.
Sun T, Zhang Y, Li H, Liu X, Yi D, Tian L . Sperm DNA fragmentation index, as measured by sperm chromatin dispersion, might not predict assisted reproductive outcome. Taiwan J Obstet Gynecol. 2018; 57(4):493-498. DOI: 10.1016/j.tjog.2018.06.003. View